Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
WORKING PAPERS
March 27, 2024
The inflow of refugees and their subsequent integration can be an important challenge for both the refugees themselves and the host society. Policy interventions can improve the lives and economic success of refugees and of their communities. In this paper, we review the socioeconomic integration po...
Blog Post
March 27, 2024
When refugees fleeing conflict and persecution arrive in a new country, they need immediate humanitarian support. Shelter, food, safety, and health are rightly considered nonnegotiable priorities by the international community. But once these basic needs are satisfied, how do we promote refugees’ so...
CGD NOTES
January 30, 2024
As policymakers in protracted refugee situations shift from short-term humanitarian responses to longer-term development support, it is critical to identify effective approaches for allocating scarce resources. Hundreds of millions of dollars are spent on livelihood programs for refugees annually, y...
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
POLICY PAPERS
November 28, 2022
The experience of the COVID-19 pandemic—in the US and around the world—highlights the potential feasibility and importance of biomedical R&D for global health and welfare. Drawing from this experience and momentum, this paper argues that the US should deepen its engagement and ambition in global hea...
Blog Post
November 28, 2022
Building on the success of Operation Warp Speed, the US should deepen its engagement and ambition in global health R&D to drive transformative improvements in global health outcomes and security. Specifically, it should consider a subscription model for new antimicrobials; an advance market commitme...
POLICY PAPERS
November 15, 2022
Antimicrobial drugs form the backbone of modern medicine. Yet over time, use of these drugs selects for mutations that survive exposure to those same drugs, driving “antimicrobial resistance,” or AMR. In the absence of sufficient R&D investment for new antimicrobials, deaths from drug-resistant infe...